$GEF

Insider Buying Week 03-15-24

by

Insider buying has been noticeably scarce in this bull leg of a market making all-time highs. The small amount of buying is not performing particularly well either.  You might find this news surprising from a hedge fund manager who has made a living reading these tea leaves for 23 years. Name: Ole G Rosgaard Position: President and CEO Transaction Date: 2024-03-08 Shares Bought: 4,914 Average Price Paid: $67.00 Cost: $329,235 Company: Greif Inc (GEF) Greif Inc. is a top global provider of industrial packaging goods and services, with operations in over 35 countries. The company provides a wide range of … Read more

Bye Bye Jay Time for Another Chair Insider Buying Week 3-24-23

by

We are deep in the darkness, the earnings blackout period in which corporate insiders are restricted from buying their own shares. It’s a perfect time for short sellers to prey on the frazzled nerves of investors that just experienced their first bank run since the Great Financial Recession of 2008. This time the run wasn’t caused by Wall Street and banks that sold liars loans to uncreditworthy customers but instead by the monetary policy of the Federal Reserve itself. Jay Powell left interest rates at zero far too long and raised them far too fast. He failed at running the … Read more

‘m Giving Robert Coury another Change to F*ck Me, Insider Trading Week Ending 12-18-20

by

For trade details click on this link to the trades   PROGENITY Inc up 38.05%  COO Silvestry bought 58,081 shares of PROG at $4.58.  Progenity announced on December 17th  that it is expanding the availability of COVID-19 RT-PCR testing across the United States to support the rising demand for testing. Testing is performed using the Thermo Fisher Applied Biosystems TaqPath COVID-19 Combo Kit, under Emergency Use Authorization by the FDA. Although the stock rocketed on this news combined with insider buying, it’s been a rough haul for shareholders.  Give this one a little time to pullback. PROG recently did a … Read more

Insiders Largely Immune from Tech Momentum Sell-Off

by

The Insider Fund had one of its best weeks this year, largely immune from the Nasdaq market momentum collapse. Investors that lack confidence bail easily.  Nothing engenders confidence more than seeing corporate insiders buying their own stock. The finger points the way to real time results.  If you are interested in our trades, follow us on Twitter.   CASSAVA SCIENCES INC  43.21% IGM Biosciences Inc.    38.01% Party City Holdco Inc.  18.49% FLEXSTEEL INDUSTRIES INC  16.10% GUESS INC  13.94% CHARLES & COLVARD LTD  13.51% Franchise Group Inc.  8.80% Biohaven Pharmaceutical Holding Co Ltd.   7.64% FLOTEK INDUSTRIES INC  6.25%  CRYOLIFE INC  4.51% SCHLUMBERGER LIMITED  4.35% AFFILIATED MANAGERS GROUP … Read more

The Home is Hot, but Not Much Else- Insider Buying Tapers off with 3rd Quarter Earnings Blackout

by

The market has been trending lower, all major averages are testing the 50 day moving average.  In this kind of juiced up market, technical traders have an unwarranted influence. My guess is that we will undercut the moving average in a test of investor faith but this could go on for weeks if not months. Investors that lack confidence bail easily.  Short sellers know that- and they also know that corporate insiders are blacked out. Most companies have self-imposed restrictions on buying or selling their companies’ stock insider thirty days from quarter end. The following companies had large insider buying last week.  We are digging … Read more